SYSTEMATIC FINANCIAL MANAGEMENT LP
Position in CPRX — Catalyst Pharmaceuticals, Inc.
CIK 1085936
TEANECK, NJ
Position in CPRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$18,508,470
+$1,628,002 QoQ
Shares Held
747,515
+3.4% QoQ
Ownership
0.611%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
6 quarters on record
Voting authority
Sole 56%
Shared 0%
None 44%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SYSTEMATIC FINANCIAL MANAGEMENT LP holds $191,675,128 across 6 Biotechnology names. CPRX ranks #4 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
407,114 | $76,964,901 | |
| 2 | INVA |
Innoviva, Inc.
|
2,024,082 | $47,161,110 | |
| 3 | EXEL |
Exelixis, Inc.
|
709,127 | $30,414,456 | |
| 4 | CPRX |
Catalyst Pharmaceuticals, Inc.
This page
|
747,515 | $18,508,470 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
255,354 | $14,424,947 | |
| 6 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
1,484,539 | $4,201,244 |
All Filings in CPRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,508,470 | 747,515 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $16,880,468 | 723,242 | Shares | Other | 2026-02-09 | |
| 2025-09-30 | $13,507,580 | 685,664 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $4,223,471 | 194,630 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $4,398,706 | 181,390 | Shares | Other | 2025-05-14 | |
| 2020-06-30 | $312,612 | 67,665 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||